EOJOAM
SAGE

E. Ohman J:or Asset Management’s Sage Therapeutics SAGE Stock Holding History

E. Ohman J:or Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-55,595
Closed -$10.2M – 381
2019
Q2 		$10.2M Hold
55,595
– – 0.67% 32
2019
Q1 		$8.84M Buy
+55,595
New +$8.05M 0.6% 42

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

E. Ohman J:or Asset Management's SAGE Position: Q3 2019 in Review

E. Ohman J:or Asset Management sold out of Sage Therapeutics (SAGE) in Q3 2019, closing a stake of 55,595 shares — an estimated $10.2M sold.

E. Ohman J:or Asset Management first reported a position in SAGE in Q1 2019 and held it in 2 quarters. The position peaked at $10.2M in Q2 2019. 284 funds tracked by Wall St. Rank hold SAGE as of Q3 2019.

  • E. Ohman J:or Asset Management reported no remaining Sage Therapeutics position as of Q3 2019 after selling out during the quarter.
  • E. Ohman J:or Asset Management sold 55,595 Sage Therapeutics shares in Q3 2019, an estimated $10.2M.
  • E. Ohman J:or Asset Management first reported a position in Sage Therapeutics in Q1 2019 and held it in 2 quarters.
  • E. Ohman J:or Asset Management's Sage Therapeutics position peaked at $10.2M in Q2 2019.
  • 284 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2019.

Based on E. Ohman J:or Asset Management's 13F filing for Q3 2019, filed 5 Apr 2024.